Ketek
Frequently Asked Questions
What are my legal options?
If you believe you have suffered liver damage as a result of taking Ketek®, your legal options may include the right to be compensated for any injury you suffered as well as for the expense, mental anguish and inconvenience you may have suffered.
What are the legal fees?
There are no legal fees unless you receive compensation in the form of a settlement or award. This is called a contingent fee and is a percentage of your award. We are only entitled to such a fee if we are successful in obtaining an award or settlement for you.
Do I have to advance money for costs?
No, you do not have to advance any moneys for costs. We will advance the money necessary to pay for the out-of-pocket costs required to prosecute your case. If you receive a settlement or award, we will be reimbursed out of the settlement for the costs we advanced on your behalf. If you do not receive a settlement or award, you owe nothing.
How soon will you begin work on my case?
As soon as we receive a signed Retainer Agreement, we will begin work on your case. The initial phase of this work will be to obtain medical records and evaluate your potential claims. To do so, you also need to sign and return HIPPA medical releases. IF AVAILABLE TO YOU, PLEASE BE SURE TO INCLUDE A COPY OF YOUR KETEK® BOTTLE WITH PRESCRIPTION INFORMATION, OR, IF YOU CANNOT COPY IT, WRITE THE INFORMATION DOWN ON A PIECE OF PAPER – INCLUDING THE NAME AND ADDRESS OF THE PHARMACY THAT FILLED YOUR PRESCRIPTION –
What should I do if I have concerns about my use of Ketek® and my health?
You should contact your doctor if you have concerns about your health. You and your doctor can discuss your concerns and options.
|
 |
|
Do You Have A Potential Ketek Case?
Contact Us Today! |
 |
Ketek
Current News
Health Canada Endorsed Important Safety Information on Ketek (telithromycin)
Sanofi-aventis Canada Inc. in consultation with Health Canada would like to inform health care professionals of important updated safety information regarding Ketek (telithromycin) tablets. Based on information in published case reports and post-market adverse event reports, the Canadian Product ...read more
FDA Completes Safety Assessment of Ketek New Safety Information to be Added to Product Labeling
The Food and Drug Administration (FDA) today completed its safety assessment of Ketek (telithromycin) and is advising health practitioners and patients to be aware of rare but potentially serious health risks. Ketek is the first FDA-approved antibiotic of the ketolide class. It is indicated for the ...read more
|
|
|
